multi-omic solutions for advanced healing

future therapeutics for a healthier now

At ome, we're not just bringing breakthrough technologies to the world - we're giving our partners and backers early access to them. By combining stem cell science, omics data, and AI-powered precision medicine, we're accelerating the next generation of cell therapies and reinventing therapeutic manufacturing.

Through our global network of public and private partners - from regulators and hospitals to defense and tech - we reduce time to market and increase real-world impact. Together, we're building a healthier now, not just a better someday.

FOCUS ZONES

beyond boundaries. built for outcomes.

many-modal therapies

We back therapeutic platforms that transcend the limits of any one modality. Whether it's a biologic, peptide, cell therapy, gene therapy, or electroceutical, we invest where innovation and impact intersect.

dual-use innovation

resilience for all - civilian and defense

Ome identifies and accelerates platforms with military and civilian relevance - such as trauma-ready biologics, battlefield diagnostics, and performance-optimizing regenerative tools. We unlock value for our portfolio through defense partnerships, non-dilutive capital sourcing, and global health alignment.

AI-driven health

data is the drug.

We harness omics-scale data, AI, and digital biomarkers to guide the discovery, delivery, and optimization of next-generation therapies. Whether enabling precision trials, or decentralized protocols, our companies turn intelligence into outcomes.